PF-06801591
B8011006
Phase 3 small_molecule active
Quick answer
PF-06801591 for Non-muscle Invasive Bladder Cancer is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Non-muscle Invasive Bladder Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active